Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial
Clinical trial NCT05083312 · COMPLETED
Trial details
- NCT number
- NCT05083312
- Sponsor
- Ellodi Pharmaceuticals, LP
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2022-09-05
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.